STOCKS TELEGRAPH

Tag: HUGE

  • FSD Pharma Inc. (HUGE) Stock Strides Up After Hours While There is No Official Announcement

    On February 04, FSD Pharma Inc. (HUGE) gained a further 7.10% after hours while there was no official announcement from the company.

    Friday’s regular session witnessed a below-average volume of 120.14K shares. The HUGE stock closed the regular session at $0.8310, just above its 52-week low of $0.8100. The stock while barely kept in the green with a gain of 0.48% in regular trading, added a good value after hours. Hence, HUGE was trading at $0.8900 per share after hours on Friday.

    The specialty biotech pharmaceutical R&D company, FSD Pharma Inc. has a market capitalization of $32.91 million. Currently, the company has 49.42 million shares outstanding in the market.

    HUGE stock Movement

    During Friday’s regular session, HUGE stock brushed down to its 52-week low of $0.8100 and closed the session just above it. Since there is no official news or SEC filing, the stock seems to have gained because of the new low. It seems like the new low provided a good buying opportunity to investors. Therefore, the stock made a big stride up in the after-hours while it barely kept in the green during regular trading.

    In the past five days, the stock has decreased by 5.57% while losing 18.53% year to date. Moreover, HUGE stock subtracted a value of 64.03% last year.

    Launch of New Corporate Website

    On January 20, the company announced the launch of its newly designed corporate website. The new website elaborately specifies HUGE’s emerging position along with its brain and inflammatory disorders’ novel treatment commitment. Furthermore, the website’s new look is very user-friendly for not only investors but also patients, researchers, and clinicians. It educates all users about the company’s unique approach for total brain health.

    According to the Interim CEO, Anthony Durkacz, the company has strategically assembled a team of scientists for developing its next-gen therapeutics pipeline. Currently, the company’s lead drug candidates are Lucid-MS, Lucid-PSYCH, and FSD-PEA.

    HUGE’s Other Developments

    In 2022, Elanor N. Fish, Ph.D., member of HUGE’s Research & Clinical Advisory Board was appointed to the Order of Canada. The background for this appointment was her contributions to immunology along with groundbreaking studies.

    The Order of Canada, the country’s highest civilian honors, was created in 1967. The Governor-General on the recommendation of the Advisory Council for the Order of Canada makes the appointments.

    On January 10, the company participated in the H.C. Wainwright BioConnect Conference which was held virtually.

  • Share Repurchase Program: FSD Pharma Inc. (HUGE) stock Hikes Premarket

    Share Repurchase Program: FSD Pharma Inc. (HUGE) stock Hikes Premarket

    On December 30, FSD Pharma Inc. (HUGE) announced a share repurchase program in order to return value to its shareholders. Consequently, the stock was trading at $1.02 apiece with a 3.78% gain premarket, at the last check.

    In the previous trading session, the HUGE stock barely remained in the green with a slight gain of 0.05% at $0.9828. Following the announcement, the stock made a huge jump in the premarket session.

    HUGE stock and its Movements

    The specialty biotech pharmaceutical research and development company, FSD Pharma Inc. was founded in1994. Based in Canada, the company has a market capitalization of $39.71 million. Currently, the company has 40.42 million shares outstanding in the market.

    In the past five days, HUGE stock has witnessed a loss of 7.28%, while losing 16.00% last month. Moreover, the stock has subtracted a value of 36.18% in the past three months and 37.00% year to date.

    Share Repurchase Program

    On Thursday, the company announced to strategically return value to shareholders with its excess cash reserves. HUGE’s board of directors authorized the repurchase of up to 2,000,000 of its Subordinate Class B Voting Shares. Moreover, the company will repurchase the shares at the market price over the next twelve months. Furthermore, these shares represent 5% of the company’s issued and outstanding Subordinate Voting Shares.

    According to the Interim CEO of HUGE, Anthony Durkacz, the company had cash and cash equivalents of over 39.3 million on September 30, 2021. Given the huge sum, the company is taking the strategic opportunity of returning value to its shareholders.

    Further, the commencement date of the share repurchase program is January 4, 2022. Moreover, the program is expected to terminate on December 30, 2022. In addition, the company may decide to terminate the share repurchase program at any time upon its discretion. The purchase of Subordinate Voting Shares would be canceled by the company.

    Other Recent Developments

    On December 09, HUGE announced the formation of a Regulatory Advisory Board (RAB). Furthermore, the company has appointed Joga Gobburu and Mary Melnyk as members of the board.

    Dr. Gobburu is a renowned scientific leader in pharmacometrics. Moreover, he is a Professor at the School of Pharmacy and the School of Medicine, University of Maryland, Baltimore, MD. Over the years, he has also served in various positions at the U.S. FDA.

    Expert in manufacturing and regulatory requirements, Dr. Melnyk is currently the Senior Regulatory Consultant at Innovalinks. Moreover, she has also served at the Academy of Applied Pharmaceutical Science, Biovail Corporation, EMD Merck Biomira, Novartis Canada/CIBA Division, and many others.

  • Let’s find out what is making F.S.D. Pharma Inc. (HUGE) stock standout today?

    Let’s find out what is making F.S.D. Pharma Inc. (HUGE) stock standout today?

    Even experienced traders find the stock market to be quite bewildering at times. There are times when, even when the results are as expected, the market just seems to turn in the opposite direction, leading to doubts and speculation. A good strategy might include keeping track of a stock’s price performance in the past, as well as keeping an eye on its trends in the short-term and long-term. Over the past week, F.S.D. Pharma Inc. (Nasdaq: HUGE) stock prices have decreased by 7.25%, but they have increased 19.65% over the last quarter. Throughout the previous six months, the stock’s value fell over -2633% but is currently up over 32.69% for the year.

    What is hot at the moment?

    March 17, 2021, it is disclosed that F.S.D. Pharma Inc. (Nasdaq: HUGE) has agreed to license ultra micronized-palmitoylethanolamide with Innovet Italia S.R.L. to manufacture FDA-approved veterinary drugs for treating gastrointestinal diseases in dogs and cats. Additionally, the Company today released its year-end finance and corporate results.

    The deal with Innovet Italia S.R.I., is an opportunity for the Company to enter a new and untapped market. Our balance sheet’s strength allows us to explore other M&A and license options to expand our drug development pipeline, said led by Dr. Raza Bokhari, executive chairman and C.E.O.

    Key points of the License Agreement

    • This agreement gives the Company the exclusive worldwide rights to develop, manufacture, and market products utilizing specific unique formulations of ultra-micro P.E.A. to treat gastro-intestinal problems in canines and felines.
    • A provision of the License Agreement requires the Company to develop the Licensed Products in order to submit an Investigational Animal Drug Application within 36 months from the date of the agreement and a New Animal Drug Application within 60 months after the effective date of the agreement.
    • Under the License Agreement terms, Innovet will receive payments from the Company upon achievement of certain milestones.
    • There is also a certain royalty payment specified in the License Agreement.
    • Additionally, the Company is obliged to pay 5% of net sales on products licensed from the Company.

    Major Business Updates

    • A special shareholders’ meeting is scheduled for May 14, 2021, at the Company’s annual meeting.
    • At the 2021 A.G.M., April 15 is the record date for voting.
    • Shareholders will receive the Company’s management information circular and proxy materials before April 23, 2021.
    • The 2021 Annual General Meeting replaces the shareholder meeting of June 29, 2021, announced earlier.

    What Analysts make of HUGE stock?

    The HUGE stock price may go up by 79.3%, according to Market Gurus. The shares were to achieve a high price target of $10.00 in the next 12 months. Analysts also predict that traders would keep stock prices between $10.00 and $15.00. Overall, HUGE’s price is up 32.69% this year.

  • Market Movers: What changed for these 28 stocks while you were sleeping

    Market Movers: What changed for these 28 stocks while you were sleeping

    Aurora Cannabis Inc. (NYSE: ACB) shares are trading down -15.66% at $7.0 at the time of writing. The company’s 52-week range was noted as $3.71 to $45.48. Meanwhile, Aurora Cannabis revealed Proposed Public Offering.

    Pareteum Corporation (TEUM) tumbled over -57.47% at $0.1999 in pre-market trading today after Pareteum Delivered Business Update in Open Letter to Shareholders.

    Waitr Holdings Inc. (WTRH), a Software – Application company, rose about 6.59% at $2.75 in pre-market trading Wednesday.

    Jumia Technologies AG (JMIA) stock moved up 4.49 percent to $13.49 in the pre-market trading after Jumia posted Third Quarter 2020 Results.

    Tilray Inc. (TLRY) lost over -5.76% at $7.85 in pre-market trading Wednesday 11 November 2020 after the pot company vows profit despite slow sales growth.

    9F Inc. (JFU) is up more than 6.73% at $1.11 in pre-market hours Wednesday 11 November 2020 after the company shares had dropped over -14.75% to $1.04 in the last trading session.

    InnSuites Hospitality Trust (IHT) stock plunged -6.86% to $1.9 in the pre-market trading.

    Before the trading started on 11 November 2020, Destination XL Group Inc. (DXLG) is up 6.32% to reach $0.3296 after the largest omni-channel specialty retailer of big & tall men’s apparel, revealed on November 06, 2020, to announce its third-quarter 2020 results before the market opens on Friday, November 20, 2020. The stock has been trading in a 52-week range of $0.22 to $1.56.

    Novavax Inc. (NVAX) stock soared 5.28% to $82.9 in the pre-market trading following the news that Novavax, working with Morrisville firm, secured fast-track status for Covid-19 vaccine candidate. The most recent rating by H.C. Wainwright, on August 06, 2020, is at a Buy.

    Carnival Corporation & plc (NYSE: CUK) shares are trading up 6.02% at $15.67 at the time of writing after the company announced the sale of 67.1 million shares of Carnival Corporation common stock under its previous $1 billion “on the market” stock offering plan. The company’s 52-week range was noted as $7.08 to $49.03.

    Ballard Power Systems Inc. (BLDP) grew over 4.91% at $15.81 in pre-market trading today after its latest performance.

    Farfetch Limited (FTCH), an Internet Retail company, rose about 4.54% at $42.86 in pre-market trading Wednesday following the announcement on November 5, 2020, that Alibaba and Richemont will be investing $600 million in private convertible notes issued by Farfetch Limited.

    FSD Pharma Inc. (HUGE) stock moved up 14.39 percent to $1.59 in the pre-market trading as Raza Bokhari, CEO of FSD Pharma Inc (NASDAQ: HUGE), revealed that the biopharma company is fully funded to continue progress in its Phase 2 trial on the treatment of patients with hospitalized coronavirus.

    Fuel Tech Inc. (FTEK) gained over 64.26% at $1.25 in pre-market trading Wednesday 11 November 2020 after Fuel Tech Reported 2020 Third Quarter Financial Results.

    HEXO Corp. (HEXO) is down more than -3.88% at $0.75 in pre-market hours Wednesday 11 November 2020 following the announcement by the company that Health Canada has granted Trent MacDonald’s security clearance request under the Cannabis Act. The stock had dropped over -5.99% to $0.78 in the last trading session.

    Before the trading started on 11 November 2020, Phoenix Tree Holdings Limited (DNK) is up 4.61% to reach $1.59. It has been trading in a 52-week range of $1.27 to $13.90.

    DouYu International Holdings Limited (DOYU) stock soared 4.7% to $14.25 in the pre-market trading as China’s leading game-centric live streaming site and a leader in the value chain for eSports, today revealed its financial results for the third quarter. The most recent rating by China Renaissance, on November 05, 2020, is at a Hold.

    Sundial Growers Inc. (NASDAQ: SNDL) shares are trading down -13.38% at $0.3794 at the time of writing following the report that Sundial Growers Inc. (NASDAQ: SNDL) Shares Could Be 47% Below Their Intrinsic Value Estimate. The company’s 52-week range was noted as $0.14 to $4.02.

    Lyft Inc. (LYFT) grew over 5.69% at $38.1 in pre-market trading today following the news that it was working on a new service to take a slice of the burgeoning food-delivery market as it works to make up for a 48% drop in quarterly revenue and a slow recovery of ride-hail demand.

     

    Li Auto Inc. (LI), an Auto Manufacturers company, dropped about -3.21% at $24.43 in pre-market trading Wednesday after the company today announced a voluntary recall on some of its Li ONEs.

     

    Gulfport Energy Corporation (GPOR) stock moved up 6.75 percent to $0.28 in the pre-market trading.

     

    Ayro Inc. (AYRO) is down more than -4.98% at $2.67 in pre-market hours Wednesday 11 November 2020. The stock had dropped over -3.77% to $2.81 in the last trading session.  An engineer and manufacturer of light-duty, urban, and short-haul electric vehicles (EVs), on November 6, 2020, announced financial results for its third quarter of 2020.

     

    Before the trading started on 11 November 2020, Cellectar Biosciences Inc. (CLRB) is up 7.14% to reach $1.2 after, Maxim Group analyst Jason McCarthy assigned a buy rating to Cellectar Biosciences (CLRB) and set a $3.00 price target. It has been trading in a 52-week range of $1.01 to $3.33.

     

    GameStop Corp. (GME) stock soared 5.41% to $11.7 in pre-market trading. The most recent rating by Jefferies, on October 12, 2020, is at a Hold. The company announced that it will redeem $125 million in principal amount of its 6.75% Senior Notes due 2021 on December 11, 2020. This voluntary early redemption covers approximately 63% of the outstanding Notes.

     

    Weidai Ltd. (NYSE: WEI) shares are trading down -3.47% at $1.39 at the time of writing. The company’s 52-week range was noted as $0.73 to $6.40.

     

    Performant Financial Corporation (PFMT) grew over 10.16% at $1.03 in pre-market trading today after a leading provider of technology-enabled recovery and related analytics services in the United States, today reported financial results for its third quarter ended September 30, 2020.

     

    Five Prime Therapeutics Inc. (FPRX), a biotechnology company, rose about 278.46% at $20.21 in pre-market trading Wednesday after the company had announced that its gastric cancer drug met all three of its Phase 2 study efficacy endpoints.

     

    Datadog Inc. (DDOG) stock moved down -9.3 percent to $83.99 in the pre-market trading following an estimate-beating sales outlook, but investors who have seen the stock more than double this year have not been pleased. Furthermore, Datadog Released Monitoring Features for Detecting and Debugging DNS Issues.

     

     

     

     

     

  • FSD Pharma [NASDAQ: HUGE] Decides To File IND For FSD201 To Treat COVID-19 Patients

    FSD Pharma [NASDAQ: HUGE] Decides To File IND For FSD201 To Treat COVID-19 Patients

    FSD Pharma Inc. [NASDAQ: HUGE] has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) to gain approval for the use of FSD201 to treat COVID-19 patients, the company disclosed today.

    FSD201 has anti-inflammatory properties that are proven to be useful to avoid cytokines storm linked with acute lung injury in hospitalized COVID-19 patients.

    FSD share traded up 6.23% during the trading session of Friday. This company has an opening price of $3.04 and closed at $3.24. HUGE has a day low and high range of $3.00-$3.25, respectively.

    It had a trading volume of 475.46K as compared to the average volume of roughly 932.84K. This company has a total market capitalization of 42.06 million.

    In the past 52-weeks of trading, this company’s stock has fluctuated between the low of $2.39 and a high of $17.49. Its shares traded up 35.56% from its 52-weeks low and traded down -81.47% from its 52-weeks high.

    The FSD201 COVID-19 trail will be conducted at 25-30 sites to check the safety and efficacy of FSD201. Furthermore, the Board of Directors has given the official approval regarding the issuance of additional 369,255 class B subordinate voting shares to certain of the directors, officers, employees, and consultants of the company. This step is taken to provide the share-based compensation.

    Additionally, it is also disclosed that Dr. Raza Bokhari has got 805,802 Class B Shares instead of cash compensation for his services as CEO and Executive Co-Chairman of the Company. Dr. Bokhari has now gained ownership of approx. 8.5% of issued and outstanding class B shares. He also has control over  33.3% of the outstanding Class A multiple voting shares of the company.